Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Area of Science:

• Pharmacogenomics
• Enzymology
• Molecular Biology

Background:

• Cytochrome P450 2D6 (CYP2D6) genetic polymorphism significantly influences drug metabolism and systemic exposure.
• Understanding novel CYP2D6 variants and their kinetic properties is crucial for personalized drug therapy.

Purpose of the Study:

• To identify novel CYP2D6 variants and characterize their enzymatic kinetic properties.
• To elucidate the structure-function relationship of identified CYP2D6 variants.

Main Methods:

• Population-based sequencing to discover variants.
• Baculovirus insect cell expression system for protein production.
• In vitro enzymatic assays with dextromethorphan as a probe substrate.
• Ultrahigh performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for kinetic analysis.

Main Results:

• Nine novel missense mutations in CYP2D6 exonic regions were identified.
• Variants CYP2D6.2, 10, 17, 35, 65, R28G, T76M, and E215K showed significantly reduced enzyme activity.
• CYP2D6 D301V variant exhibited near-complete loss of function, while R25Q showed increased relative clearance.
• Mutation sites are located outside the substrate binding pocket, suggesting allosteric modulation of enzyme activity.

Conclusions:

• Novel CYP2D6 variants have been discovered and their functional impact characterized.
• Enzyme kinetics and structural analysis provide insights into allosteric modulation of CYP2D6 activity.
• Findings support the precise application of CYP2D6 substrate drugs in personalized medicine.